TEXAS CAPITAL BANCSHARES INC/TX
Data quality: 83%
TCBIO
NASDAQ
Financial Services
Depository Institutions
$22.03
▲
$0.01
(0.02%)
6 months return
—
Momentum
Neutral
1Y earnings growth
326.08%
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)326.08%
FCF Growth (3Y)-1.38%
Quality
Return on Equity
9.24%
Above sector avg (9.22%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.17
Below sector avg (0.49)
Current RatioN/A
Interest CoverageN/A
Valuation
PE (TTM)
3.04
Below sector avg (11.12)
P/B Ratio0.28
EV/EBITDAN/A
Dividend Yield6.59%
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Earnings grew 326.08% over the past year
Debt/Equity of 0.17 — conservative balance sheet
Generating 347.59 M in free cash flow
P/E of 3.04 — trading at a low valuation
PEG of 0.45 suggests growth is underpriced
Cash machine — converts 105.25% of earnings into free cash flow
Price History
Financial Trends
Analyst Price Target
No analyst coverage available
Growth
Rev 5Y: N/A · Earnings 1Y: 326.08%
Growth
Rev 5Y: N/A · Earnings 1Y: 326.08%| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 326.08% | Earnings Growth (3Y) | 32.14% |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | 6.79% |
Profitability
ROE: 9.24% · Net Margin: N/A
Profitability
ROE: 9.24% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | 330.24 M |
| ROE | 9.24% | ROA | 1.02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | 347.59 M |
| ROIC | N/A | FCF Growth (3Y) | -1.38% |
Safety
D/E: 0.17 · Current: N/A
Safety
D/E: 0.17 · Current: N/A| Debt / Equity | 0.17 | Current Ratio | N/A |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | N/A | Tangible Book Value | 3.64 B |
Dividends
Yield: 6.59% · Payout: 21.15%
Dividends
Yield: 6.59% · Payout: 21.15%| Dividend Yield | 6.59% | Payout Ratio | 21.15% |
| Dividend Growth (3Y) | 0.00% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 5 yrs | ||
Valuation
P/E: 3.04 · EV/EBITDA: N/A
Valuation
P/E: 3.04 · EV/EBITDA: N/A| P/E Ratio | 3.04 | Forward P/E | N/A |
| P/B Ratio | 0.28 | P/S Ratio | N/A |
| PEG Ratio | 0.45 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 0.69 | Fwd Earnings Yield | N/A |
| FCF Yield | 34.60% | ||
| Market Cap | 1.00 B | Enterprise Value | 1.63 B |
Per Share
EPS: 6.79 · FCF/Share: 7.54
Per Share
EPS: 6.79 · FCF/Share: 7.54| EPS (Diluted TTM) | 6.79 | Revenue / Share | N/A |
| FCF / Share | 7.54 | OCF / Share | 7.81 |
| EPS CAGR (1Y) | 430.47% | EPS CAGR (5Y) | 10.22% |
| EPS CAGR (10Y) | 9.06% | ||
Efficiency
FCF Conv: 105.25% · CapEx/Rev: N/A
Efficiency
FCF Conv: 105.25% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 105.25% |
| SBC-Adj. FCF | 312.52 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | 330.24 M | 77.51 M | 189.14 M | 332.48 M | 253.94 M |
| EPS (Diluted) | 6.79 | 1.28 | 3.54 | 6.18 | 4.60 |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | 52.17 M | 54.23 M | 40.47 M | 45.28 M | 93.41 M |
| Interest Expense | 1.03 B | 901.30 M | 715.80 M | 268.48 M | 107.75 M |
| Income Tax | 102.47 M | 29.55 M | 57.45 M | 99.28 M | 84.12 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 31.54 B | 30.73 B | 28.36 B | 28.41 B | 34.73 B |
| Total Liabilities | 27.91 B | 27.36 B | 25.16 B | 25.36 B | 31.52 B |
| Shareholders' Equity | 3.63 B | 3.37 B | 3.20 B | 3.06 B | 3.21 B |
| Total Debt | 620.58 M | 660.35 M | 859.15 M | 931.44 M | 928.74 M |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | — | — | — | — | — |
| Current Liabilities | — | — | — | — | — |
Peer Comparison
vs Financial Services sector median (6628 peers)
Compared with similar companies in Financial Services
Peer Comparison
vs Financial Services sector median (6628 peers) Compared with similar companies in Financial Services| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 3.0 | 11.1 |
| P/B | 0.3 | 1.2 |
| ROE % | 9.2 | 9.2 |
| Net Margin % | — | 9.4 |
| Rev Growth 5Y % | — | 5.8 |
| D/E | 0.2 | 0.5 |
Dividend History
Dividend History
Yield
6.59%
Payout ratio
21.15%
Growth (3Y)
0.00%
Growth (5Y)
N/A
Recent per-share payments (most recent first).
| Ex-dividend | Payment | Amount / share |
|---|---|---|
| Mar 02, 2026 | — | $0.36 |
| Dec 01, 2025 | — | $0.36 |
| Sep 02, 2025 | — | $0.36 |
| Jun 02, 2025 | — | $0.36 |
| Mar 03, 2025 | — | $0.36 |
| Dec 02, 2024 | — | $0.36 |
| Sep 03, 2024 | — | $0.36 |
| Jun 03, 2024 | — | $0.36 |
| Feb 29, 2024 | — | $0.36 |
| Nov 30, 2023 | — | $0.36 |
| Aug 31, 2023 | — | $0.36 |
| May 31, 2023 | — | $0.36 |
Strategy Scores
3 strategies matched
Strategy Scores
3 strategies matchedRecent Activity
Entered
High Yield Value
Apr 12, 2026
Entered
Deep Value Investing (Seth Klarman)
Apr 12, 2026
Entered
Defensive Investing (Benjamin Graham)
Apr 12, 2026
{"event":"ticker_viewed","properties":{"ticker":"TCBIO","listing_kind":"stock","pathname":"/stocks/tcbio","exchange":"NASDAQ","country":"US"}}